#24-424 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
#24-425 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Medicover to evaluate a potential separate listing in india
Reading Time: < 1 minute The board of directors of Medicover AB (Publ) has today decided to evaluate the opportunity to list the Indian hospital subsidiary in India over the coming 12-24 months to further support its growth ambitions in the fast-growing Indian market. Medicover
Lundin Mining Publishes Swedish Short Form Document for Offer of New Lundin Mining Shares in Connection with the Acquisition of Filo Corp.
Reading Time: 4 minutes VANCOUVER, BC, December 10, 2024 /CNW/ – (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) is pleased to announce that Lundin Mining’s Swedish short-form document prepared in accordance with Article 1.4 da) and Annex IX of
Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU
Reading Time: 4 minutes Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase 3 study using 8 weeks of daily dosing followed by weekly maintenance dosing. The company’s focus going forward will be on the effective
Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU
Reading Time: 4 minutes Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase 3 study using 8 weeks of daily dosing followed by weekly maintenance dosing. The company’s focus going forward will be on the effective
FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.12.2024
Reading Time: < 1 minute Stock Exchange Release 10.12.2024 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.12.2024 Date 10.12.2024 Exchange transaction Buy Share class FSKRS Amount 2,000 Average price/share 14.4600 EUR Highest price/share 14.4600 EUR Lowest price/share
Buy-back of shares in MTG during week 49, 2024
Reading Time: 2 minutes During the period between 2 December and 6 December 2024 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 90,547 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.
Zwipe AS – Subscription of new shares in the Company by exercise of subscription rights in the Rights Issue by primary insider
Reading Time: 2 minutes OSLO, NORWAY – 10 December 2024 – Reference is made to the stock exchange announcement published by Zwipe AS (the “Company“) on 6 December 2024, regarding the commencement of the subscription period in a new issue of units (the “Units“), consisting
Material Receives Splash Award for Outstanding Drupal Website
Reading Time: 3 minutes Los Angeles, United States: Material, a leading insights, marketing and technology company, is pleased to announce it is the recipient of the Splash Award in the “Education” category for work with INSEAD – The Business School for the World® and runner-up